Learn how to be more proactive by implementing robust PFAS testing and control strategies to safeguard patient health, protect your brand, and stay ahead of evolving regulations.

Optical micro overmolding combines micro molding with lead-frame or insert processes to achieve precision, clarity, and integration, demanding early collaboration to ensure manufacturability, ...

One major change introduced by the EU MDR compared to the former European directives is the inclusion of products without an intended medical purpose but with similar risk profiles to medical devices, ...

The European Union's revised Annex 1 guidelines for sterile medicinal products, effective August 2023, mandate a significant shift in how manufacturers approach risk management and contamination ...

The revised EU GMP Annex 1 guidelines have made contamination control a paramount concern for pharmaceutical manufacturers. Establishing a robust Contamination Control Strategy (CCS) is a complex ...

The European Union's Good Manufacturing Practice (EU GMP) Annex 1 has fundamentally redefined the standards for manufacturing sterile medicinal products globally. While the goal—enhancing public ...

Sharp is advancing clinical trial packaging by digitizing its operations with Tulip’s no-code platform. In an industry where trials can span a decade and cost millions, Sharp’s focus is on reducing ...

The project will create at least 200 new, full-time jobs over the next three years and retain 1,704 existing full-time positions. The Commonwealth is supporting the project with $1.5 million in state ...

Rapid prototyping has taken the medical device industry by storm, but there are pros and cons that device developers need to consider. Audit Trail Compliance And What To Look For In Mitigation ...

Current risk analysis methods focus on the possibility and severity of bad events instead of focusing directly on analyzing and improving the performance of systems and processes producing the bad ...